General
Emergency authorisation sought for coronavirus vaccines by Pfizer and Oxford-AstraZeneca in India
Emergency authorisation has been sought for the use of Pfizer and Oxford-AstraZeneca’s coronavirus vaccines in India, following the lead of the UK and Russia.
Key points:
- India has reported the second-highest number of coronavirus cases in the world
- The chief executive of one of the world’s largest vaccine producers said approval would “save countless lives”
- Experts say distribution of Pfizer’s vaccine may be difficult in India because it needs to be kept below -70 degrees Celsius
The Serum Institute of India, the world’s largest vaccine producer by volume, sought emergency authorisation in the country for Oxford-AstraZeneca’s COVID-19 vaccine.
The move came close on the heels of Pfizer applying for a similar authorisation of its coronavirus…
Continue Reading
-
Business22 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Business21 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Noosa News23 hours agoTributes continue to flow | Noosa Today
-
Noosa News21 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane